0001005794-11-000132.txt : 20110817 0001005794-11-000132.hdr.sgml : 20110817 20110817163754 ACCESSION NUMBER: 0001005794-11-000132 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110816 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20110817 DATE AS OF CHANGE: 20110817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ATRION CORP CENTRAL INDEX KEY: 0000701288 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 630821819 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32982 FILM NUMBER: 111042865 BUSINESS ADDRESS: STREET 1: ONE ALLENTOWN PARKWAY CITY: ALLEN STATE: TX ZIP: 75002 BUSINESS PHONE: 9723909800 MAIL ADDRESS: STREET 1: ONE ALLENTOWN PARKWAY CITY: ALLEN STATE: TX ZIP: 75002 FORMER COMPANY: FORMER CONFORMED NAME: ALATENN RESOURCES INC DATE OF NAME CHANGE: 19920703 8-K 1 atrion8k081611.htm ATRION CORPORATION 8-K AUGUST 16, 2011 atrion8k081611.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 

 
FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934.
 
Date of ReportAugust 16, 2011
(Date of earliest event reported)
 
Atrion Corporation
(Exact name of registrant as specified in its charter)
 
Delaware    01-10763  63-0821819
(State or other jurisdiction   (Commission File   (I. R. S. Employer
of incorporation or organization)  Number)    Identification No.)
 
One Allentown Parkway     75002
(Address of principal executive offices)     (Zip Code)

 
(972) 390-9800
(Registrant's telephone number, including area code)
 
Not Applicable
(Former Name or Former Address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 


 
Item 8.01. Other Events.
   
   On August 16, 2011, Atrion Corporation (the “Company”) issued a press release announcing that its Board of Directors updated the Company’s stock repurchase program to authorize the repurchase of up to 200,000 shares of the Company’s common stock.  A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
 
 
Item 9.01. Financial Statements and Exhibits.
   
(d)  Exhibits
 
  99.1
Press release issued by Atrion Corporation dated August 16, 2011
 
 
 
 
          
 
 

 
 

 
 

 



 
 2

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 

 
  ATRION CORPORATION
 
 
  By:    /s/ Jeffery Strickland
    Jeffery Strickland
    Vice President and Chief Financial Officer,
    Secretary and Treasurer
 
 

Date:           August 17, 2011


 
 

 


EXHIBIT INDEX
 
Exhibit No.
Description
   
99.1
Press release issued by Atrion Corporation dated August 16, 2011

EX-99.1 2 pressrelease.htm PRESS RELEASE AUGUST 16, 2011 pressrelease.htm
Exhibit 99.1
 
 
Atrion Corporation
One Allentown Parkway
Allen, TX 75002
 
 
  Atrion [logo]
   
  NEWS RELEASE
          
FOR IMMEDIATE RELEASE

ATRION CORPORATION INCREASES QUARTERLY
CASH DIVIDEND BY 17%

Stock Repurchase Program Updated

 
ALLEN, Texas (August 16, 2011) – Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors has approved an increase in the Company’s quarterly cash dividend from 42 cents per share to 49 cents per share.  Specifically, the Company’s Board of Directors declared a quarterly dividend of 49 cents per share on the Company’s outstanding shares of common stock, payable on September 30, 2011 to stockholders of record at the close of business on September 15, 2011.

The Company also announced that its Board of Directors updated the Company’s stock repurchase program, which was adopted in April 2000 and authorized the repurchase of up to 200,000 shares of the Company’s common stock.  A total of 58,105 shares remained eligible for repurchase under the April 2000 program.  The Board of Directors terminated that program, and reset the purchase level under the updated program back to a maximum of 200,000 shares.  Under the program, the Company may purchase shares of its common stock from time to time in open market and privately-negotiated transactions.  The timing of repurchases and the number of shares repurchased will be dependent on a variety of factors, including stock price, corporate and regulatory requirements and market and business conditions.  The repurchase program does not require the Company to repurchase any specific number of shares and may be terminated at any time.

Atrion Corporation develops and manufactures products primarily for medical applications.  The Company’s website is www.atrioncorp.com.

Statements in this press release that are forward looking are based upon current expectations and actual results or future events may differ materially. Such statements include, but are not limited to, Atrion’s expectations regarding repurchases of its common stock pursuant to its stock repurchase program.  Words such as “expects,” “believes,” “anticipates,” “intends,” “should,” “plans,” “will,” and variations of such words and similar expressions are intended to identify such forward-looking statements.  Forward-looking statements involve risks and uncertainties.  The following are some of the factors that could cause actual results  or future events to differ materially from those expressed in or underlying our forward-looking statements:  changing economic, market and business conditions; acts of war or terrorism; the effects of governmental regulation; competition and new technologies; slower-than-anticipated introduction of new products or implementation of marketing strategies; the Company’s ability to protect its intellectual property; changes in the prices of raw materials; changes in product mix; intellectual property and product liability claims and product recalls.  The foregoing list of factors is not exclusive, and other factors are set forth in the Company’s filings with the Securities and Exchange Commission.

 
Contact:  Jeffery Strickland
  Vice President and Chief Financial Officer
  (972) 390-9800